Mary Jo Stucky Heil
Adult Health · Mesa, AZNPI 1447271564
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations.
Across 128 payments — averaging $28.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$567
- Abbott$336
- Merck$314
- E.r. Squibb & Sons, L.L.C.$290
- Lexicon Pharmaceuticals, Inc.$217
- Sanofi-aventis U.S. LLC$208
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,64099%
- Education$110%
- Other$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 39 | $567 |
| Abbott | 5 | $336 |
| Merck | 9 | $314 |
| E.r. Squibb & Sons, L.L.C. | 5 | $290 |
| Lexicon Pharmaceuticals, Inc. | 6 | $217 |
| Sanofi-aventis U.S. LLC | 6 | $208 |
| Actelion Pharmaceuticals US, Inc. | 5 | $200 |
| Amgen | 12 | $194 |
| Boston Scientific | 3 | $179 |
| Johnson & Johnson | 5 | $168 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $162 |
| AstraZeneca | 3 | $145 |
| Novo Nordisk | 2 | $135 |
| Kestra Medical Technology Services, Inc. | 2 | $117 |
| Pfizer | 5 | $77 |
| Boehringer Ingelheim | 3 | $68 |
| Bayer | 3 | $53 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $40 |
| Baxter Healthcare | 1 | $39 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $38 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $23 |
| GSK | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Preventice Services, LLC | 1 | $14 |
| Altathera Pharmaceuticals LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$241
- CARDIOMEMS$173
- WATCHMAN FLX$132
- LifeVest$126
- Inpefa$125
- LOKELMA$124
- UPTRAVI$117
- OPSUMIT$117
- Ozempic$116
- VERQUVO$113
- Assure WCD$100
How this compares
$3,689 in reported general payments places this provider in the 85th percentile of 314 adult health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 236 | $315,201 |
| XareltoRivaroxaban | 89 | $121,751 |
| EntrestoSacubitril/Valsartan | 45 | $54,945 |
| FarxigaDapagliflozin Propanediol | 19 | $18,098 |
| BrilintaTicagrelor | 22 | $16,329 |
| Repatha SureclickEvolocumab | 13 | $10,671 |
| Praluent PenAlirocumab | 13 | $6,332 |
| Metoprolol Succinate | 373 | $5,127 |
| Losartan Potassium | 280 | $3,513 |
| Ranolazine ErRanolazine | 22 | $3,202 |
| Rosuvastatin Calcium | 164 | $2,741 |
| Prasugrel Hcl | 27 | $2,701 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 25 | $2,672 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 77 | $2,557 |
| Atorvastatin Calcium | 322 | $2,556 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $77 | $315,201236 claims |
| Johnson & JohnsonXarelto | $168 | $121,75189 claims |
| NovartisEntresto | $567 | $54,94545 claims |
| AstraZenecaFarxiga, Brilinta | $145 | $34,42741 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 314 adult health providers in Arizona.
Other adult health in Mesa
- Amy KleinhansMesa$60K
- Shauna BinetteMesa$11K
- Christine NikolicMesa$4K
- Carla GutierrezMesa$3K
- Therese SargentPhoenix$307K
- Heather McCoyScottsdale$156K
- Jennifer MylodGlendale$131K
- Natalie WilsonPhoenix$94K
- Michelle TaylorGilbert$36K
- Sherry DentonScottsdale$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.